Adipose tissue fibrosis.

Area of Science:

• White adipose tissue biology
• Extracellular matrix remodeling
• Metabolic dysfunction

Background:

• Obesity is linked to altered extracellular matrix composition and remodeling in white adipose tissue.
• Adipose tissue expansion during obesity can lead to hypoxia, activating hypoxia-inducible factor 1 (HIF-1).
• HIF-1 activation inhibits adipocyte differentiation and promotes adipose tissue fibrosis, contributing to ectopic lipid storage and metabolic dysfunction.

Purpose of the Study:

• To explore the role of hypoxia and fibrosis in white adipose tissue dysfunction during obesity.
• To investigate the impact of HIF-1 activation on adipose tissue remodeling and metabolic health.
• To identify potential therapeutic strategies for ameliorating obesity-related metabolic diseases.

Main Methods:

• Review of current literature on white adipose tissue biology, hypoxia, and fibrosis in obesity.
• Analysis of the mechanisms linking hypoxia-inducible factor 1 (HIF-1) to adipose tissue fibrosis.
• Evaluation of the association between adipose tissue fibrosis and metabolic dysfunction in preclinical and clinical settings.

Main Results:

• Hypoxia-activated HIF-1 inhibits preadipocyte differentiation and promotes adipose tissue fibrosis.
• Adipose tissue fibrosis is associated with immune cell infiltration and activation, exacerbating dysfunction.
• Evidence links adipose tissue fibrosis to metabolic dysfunction in both animal models and humans.

Conclusions:

• Therapeutic strategies including antifibrotic drugs, enhanced adipose tissue oxygen supply, or HIF-1 antagonists show promise.
• These interventions may improve white adipose tissue function, thereby ameliorating metabolic diseases associated with obesity.